UPDATE: J.P. Morgan Lowers MAKO Surgical's PT

According to a research report published this morning, J.P. Morgan has lowered MAKO Surgical's MAKO PT from $37 to $33. In the report, J.P. Morgan said, "Mako reported weak 1Q12 results on Monday evening. The company sold six Rio robots during the quarter, compared to Street consensus of nine and our own forecast for eight systems. Mako also lowered its outlook for the year, now calling for a rangeof 52-58 systems versus the prior 56-62. The company maintained its expectation for about 1/3 of system sales to come in the first half of the year, suggesting comfort with 11-13 systems for 2Q12, versus Street consensus of 12 systems." J.P. Morgan maintains its Neutral rating on MAKO Surgical, which is currently trading at $26.99.